Press Releases May 8, 2026 04:30 PM

NVIDIA Names Suzanne Nora Johnson to Board of Directors

NVIDIA strengthens its board with appointment of finance and healthcare veteran Suzanne Nora Johnson

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
NVDA

NVIDIA announced the appointment of Suzanne Nora Johnson, former Vice Chairman of Goldman Sachs and current Pfizer board member, to its board of directors effective July 13, 2026. Johnson will join the Audit Committee, expanding the board to 11 members. Her extensive experience spans finance, technology, and healthcare, providing valuable oversight as NVIDIA advances its leadership in AI and accelerated computing.

NVIDIA Names Suzanne Nora Johnson to Board of Directors
NVDA
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Suzanne Nora Johnson, with decades of leadership experience at Goldman Sachs, Pfizer, and Intuit, joins NVIDIA's board effective July 13, 2026.
  • Johnson will contribute to the Audit Committee, enhancing NVIDIA's governance and financial oversight.
  • The board expands to 11 members, reflecting NVIDIA's commitment to strong leadership as it pushes forward in AI innovation.

SANTA CLARA, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- NVIDIA today announced that it has named to its board of directors Suzanne Nora Johnson, effective July 13, 2026. Ms. Nora Johnson is the former Vice Chairman of The Goldman Sachs Group, Inc., where she spent two decades in various leadership roles, including serving as Chair of the Global Markets Institute, Head of Global Research and Head of Global Healthcare.  

She is expected to join the board’s Audit Committee on the effective date of her appointment.

“Suzanne is an extraordinary leader whose career spans finance, technology, healthcare and public policy,” said Jensen Huang, founder and CEO of NVIDIA. “Her experience guiding global companies, together with her leadership at the forefront of education and philanthropy, will be an invaluable asset to NVIDIA’s board. We are honored to welcome her and look forward to her insight as we build the future in the age of AI.”

Nora Johnson, 68, holds a J.D. from Harvard Law School and a B.A. from the University of Southern California. She serves on the board of directors of Pfizer Inc., where she is chair of the Audit Committee, a member of the Executive Committee and a member of the Regulatory & Compliance Committee. She also recently stepped down as the Board Chair of Intuit Inc., where she had served on the board of directors since 2007.

Effective on July 13, 2026, NVIDIA’s board expands to 11 members.

About NVIDIA
NVIDIA (NASDAQ: NVDA) is the world leader in AI and accelerated computing.

For further information, contact:
Mylene Mangalindan
Corporate Communications
NVIDIA Corporation
[email protected]

© 2026 NVIDIA Corporation. All rights reserved. NVIDIA and the NVIDIA logo are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries.


Risks

  • Johnson's transition from finance and healthcare to technology governance could entail a learning curve, potentially impacting board effectiveness temporarily.
  • Broader geopolitical and economic uncertainties affecting the technology sector could overshadow benefits from board changes.
  • As NVIDIA continues expanding in AI markets, regulatory and compliance risks remain significant in this fast-evolving sector.

More from Press Releases

Space Exploration Technologies Corporation to Join the Nasdaq-100 Index® Beginning July 7, 2026 Jun 26, 2026 XMax Announces Up to Approximately US$25 million in AI API-Related Service Contracts and Expansion into GPU-as-a-Service Jun 26, 2026 Cartesian Growth Corporation IV Announces Closing of $275 Million Initial Public Offering Jun 26, 2026 dLocal added to membership of US small-cap Russell 2000® Index Jun 26, 2026 Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance Jun 26, 2026